C-RAY Therapeutics Reports Fruitful Engagements at BIO 2025, Gears Up for SNMMI Annual Meeting

June 20, 2025 – As #BIO2025 draws to a close, C-Ray Therapeutics is energized by dynamic strategic collaborations with global innovators. Key highlights from our engagements at the conference include:

• Advancing Strategic Partnerships into Progress:

  • Advancing partnerships with 3 leading radiopharma developers across α/β-therapy platforms.

  • Exploring IIT co-development models with top European & US biotechs.

  • Building bridges with specialized investment firms driving nuclear medicine innovation.

  •  Receiving strong interest in our novel target discovery platforms from incubated pioneers.

C-Ray Therapeutics invites you to visit us at Booth #2128 during the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in New Orleans, June 21-24, 2025.

At our booth, meet with Ivy Chao, Vice President of Corporate Development, to discuss:

• Global Licensing Opportunities (In-licensing & Out-licensing)

• Strategic Investment Partnerships

• IIT Co-Development Models

• Novel Targets & PCC Libraries

Shaping the Future of Nuclear Medicine

Join us in New Orleans – where science meets jazz – to advance these promising discussions and explore breakthrough partnership opportunities in nuclear medicine.

Stay connected with C-Ray Therapeutics for the latest in nuclear medicine innovation.